A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 12,230 shares of MRK stock, worth $1.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
12,230
Previous 9,549 28.08%
Holding current value
$1.2 Million
Previous $1.19 Billion 17.57%
% of portfolio
0.12%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $297,993 - $345,768
2,681 Added 28.08%
12,230 $1.4 Billion
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $12,380 - $13,296
-100 Reduced 1.04%
9,549 $1.19 Billion
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $96,254 - $112,157
850 Added 9.66%
9,649 $1.28 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $881,483 - $959,266
8,799 New
8,799 $966 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.